Literature DB >> 8652371

Nuclear translocation of protein kinase C-alpha and -zeta isoforms in HL-60 cells induced to differentiate along the granulocytic lineage by all-trans retinoic acid.

G Zauli1, G Visani, A Bassini, E Caramelli, E Ottaviani, L Bertolaso, V Bertagnolo, P Borgatti, S Capitani.   

Abstract

We investigated whether members of the protein kinase C (PKC) family of enzymes were involved in the nuclear events underlying granulocytic differentiation induced by 10(-6) M all-trans retinoic acid (ATRA) in HL-60 cells. PKC activity was analysed by using a serine substituted specific peptide which enabled the evaluation of the whole catalytic activity of both Ca2+ -dependent and Ca2+ -independent PKC isoforms. In parallel, the subcellular distribution of various PKC isoforms was evaluated by Western blot, immunoprecipitation and in situ immunocytochemistry analyses. The level of PKC catalytic activity in the nuclei of HL-60 cells significantly (P < 0.01) and progressively increased from 1 h of ATRA treatment onwards. Consistently, PKC-alpha and -zeta showed a striking and selective accumulation inside the nucleus upon treatment with ATRA. On the other hand, PKC-beta I and -beta II, the only two other isoforms present at nuclear level, did not show any significant modification upon ATRA treatment. The remaining PKC isoforms were not detectable inside the nucleus and showed only modest and non-significant variations, also in whole cell homogenates, upon ATRA treatment, except PKC-delta which showed a progressive down-regulation. Our data suggest that a selective nuclear translocation of PKC-alpha and -zeta might be involved in the process of granulocytic differentiation induced by ATRA in HL-60 cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8652371     DOI: 10.1046/j.1365-2141.1996.d01-1700.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  14 in total

1.  Proliferating or differentiating stimuli act on different lipid-dependent signaling pathways in nuclei of human leukemia cells.

Authors:  Luca M Neri; Roberta Bortul; Paola Borgatti; Giovanna Tabellini; Giovanna Baldini; Silvano Capitani; Alberto M Martelli
Journal:  Mol Biol Cell       Date:  2002-03       Impact factor: 4.138

2.  The non-genotoxic activator of the p53 pathway Nutlin-3 shifts the balance between E2F7 and E2F1 transcription factors in leukemic cells.

Authors:  Maria Grazia di Iasio; Giorgio Zauli
Journal:  Invest New Drugs       Date:  2012-10-02       Impact factor: 3.850

3.  Enzastaurin enhances ATRA-induced differentiation of acute myeloid leukemia cells.

Authors:  Ze-Yi Li; Cui Liang; Ming Ding; Xiang-Qin Weng; Yan Sheng; Jing Wu; Hao Lu; Xun Cai
Journal:  Am J Transl Res       Date:  2020-12-15       Impact factor: 4.060

4.  The sorafenib plus nutlin-3 combination promotes synergistic cytotoxicity in acute myeloid leukemic cells irrespectively of FLT3 and p53 status.

Authors:  Giorgio Zauli; Claudio Celeghini; Elisabetta Melloni; Rebecca Voltan; Manuele Ongari; Mario Tiribelli; Maria Grazia di Iasio; Francesco Lanza; Paola Secchiero
Journal:  Haematologica       Date:  2012-06-11       Impact factor: 9.941

5.  Activity-dependent neurotrophic factor-14 requires protein kinase C and mitogen-associated protein kinase kinase activation to protect the developing mouse brain against excitotoxicity.

Authors:  P Gressens; S Marret; C Bodénant; L Schwendimann; P Evrard
Journal:  J Mol Neurosci       Date:  1999 Aug-Oct       Impact factor: 3.444

Review 6.  Protein kinase C in the immune system: from signalling to chromatin regulation.

Authors:  Pek Siew Lim; Christopher Ray Sutton; Sudha Rao
Journal:  Immunology       Date:  2015-10-06       Impact factor: 7.397

7.  Perifosine selectively induces cell cycle block and modulates retinoblastoma and E2F1 protein levels in p53 mutated leukemic cell lines.

Authors:  Claudio Celeghini; Rebecca Voltan; Erika Rimondi; Valter Gattei; Giorgio Zauli
Journal:  Invest New Drugs       Date:  2010-02-04       Impact factor: 3.850

8.  Treatment with recombinant tumor necrosis factor-related apoptosis-inducing ligand alleviates the severity of streptozotocin-induced diabetes.

Authors:  Giorgio Zauli; Barbara Toffoli; Maria Grazia di Iasio; Claudio Celeghini; Bruno Fabris; Paola Secchiero
Journal:  Diabetes       Date:  2010-02-25       Impact factor: 9.461

9.  Sorafenib inhibits in vitro osteoclastogenesis by down-modulating Mcl-1.

Authors:  Erika Rimondi; Paola Secchiero; Elisabetta Melloni; Vittorio Grill; Giorgio Zauli
Journal:  Invest New Drugs       Date:  2012-11-16       Impact factor: 3.850

10.  The MDM-2 antagonist nutlin-3 promotes the maturation of acute myeloid leukemic blasts.

Authors:  Paola Secchiero; Carlotta Zerbinati; Elisabetta Melloni; Daniela Milani; Diana Campioni; Roberto Fadda; Mario Tiribelli; Giorgio Zauli
Journal:  Neoplasia       Date:  2007-10       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.